Literature DB >> 16141569

Effect of antifungal drugs on cytochrome P450 (CYP) 1A2, CYP2D6, and CYP2E1 activities in human liver microsomes.

Toshiro Niwa1, Sachiko Inoue-Yamamoto, Toshifumi Shiraga, Akira Takagi.   

Abstract

The effects of five antifungal drugs, fluconazole, itraconazole, micafungin, miconazole, and voriconazole, on cytochrome P450 (CYP) 1A2-mediated 7-ethoxyresorufin O-deethylation, CYP2D6-mediated debrisoquine 4-hydroxylation, and CYP2E1-mediated chlorzoxazone 6-hydroxylation activities in human liver microsomes were compared. In addition, the effect of preincubation was estimated in order to investigate the mechanism-based inhibition. IC50 values of miconazole against CYP1A2 and CYP2D6 activities were 2.90 and 6.46 microM, respectively, and miconazole at 10 microM concentration slightly inhibited CYP2E1 activity. On the other hand, other antifungal drugs neither inhibited nor stimulated all of the metabolic activities. The stimulation of the inhibition of the metabolic activities mediated by CYP1A2, CYP2D6, or CYP2E1 by 15-min preincubation was not observed for any of the antifungal drugs, suggesting that these antifungal drugs are not mechanism-based inhibitors. These results suggest that miconazole is the strongest inhibitor against CYP1A2, CYP2D6, and CYP2E1 among the antifungal drugs investigated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16141569     DOI: 10.1248/bpb.28.1813

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  12 in total

1.  Systemic uptake of miconazole during vaginal suppository use and effect on CYP1A2 and CYP3A4 associated enzyme activities in women.

Authors:  Mia Birkhøj Kjærstad; Flemming Nielsen; Lene Nøhr-Jensen; Stine Zwisler; Kim Brøsen; Helle Raun Andersen
Journal:  Eur J Clin Pharmacol       Date:  2010-10-06       Impact factor: 2.953

2.  Miconazole oral gel increases exposure to oral oxycodone by inhibition of CYP2D6 and CYP3A4.

Authors:  Juha Grönlund; Teijo I Saari; Nora Hagelberg; Pertti J Neuvonen; Klaus T Olkkola; Kari Laine
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

3.  Autoinhibitory properties of the parent but not of the N-oxide metabolite contribute to infusion rate-dependent voriconazole pharmacokinetics.

Authors:  Nicolas Hohmann; Rebecca Kreuter; Antje Blank; Johanna Weiss; Jürgen Burhenne; Walter E Haefeli; Gerd Mikus
Journal:  Br J Clin Pharmacol       Date:  2017-05-18       Impact factor: 4.335

4.  Global patterns of variation in allele and haplotype frequencies and linkage disequilibrium across the CYP2E1 gene.

Authors:  M-Y Lee; N Mukherjee; A J Pakstis; S Khaliq; A Mohyuddin; S Q Mehdi; W C Speed; J R Kidd; K K Kidd
Journal:  Pharmacogenomics J       Date:  2008-07-29       Impact factor: 3.550

5.  Drug-induced liver graft toxicity caused by cytochrome P450 poor metabolism.

Authors:  László Kóbori; Krisztina Kõhalmy; Pálma Porrogi; Enikõ Sárváry; Zsuzsa Gerlei; János Fazakas; Péter Nagy; Jenõ Járay; Katalin Monostory
Journal:  Br J Clin Pharmacol       Date:  2007-12-07       Impact factor: 4.335

6.  Role of plasma proteins in pharmacokinetics of micafungin, an antifungal antibiotic, in analbuminemic rats.

Authors:  Fumie Abe; Jun Ueyama; Noriyo Kawasumi; Masayuki Nadai; Tamon Hayashi; Miki Kato; Masafumi Ohnishi; Hiroko Saito; Naoshi Takeyama; Takaaki Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

7.  Voriconazole drastically increases exposure to oral oxycodone.

Authors:  Nora M Hagelberg; Tuija H Nieminen; Teijo I Saari; Mikko Neuvonen; Pertti J Neuvonen; Kari Laine; Klaus T Olkkola
Journal:  Eur J Clin Pharmacol       Date:  2008-10-03       Impact factor: 2.953

8.  Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib.

Authors:  Ville V Hynninen; Klaus T Olkkola; Pertti J Neuvonen; Kari Laine
Journal:  Eur J Clin Pharmacol       Date:  2008-09-09       Impact factor: 2.953

9.  Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A.

Authors:  Seongwook Jeong; Phuong D Nguyen; Zeruesenay Desta
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

Review 10.  Cytochrome P450 family 1 inhibitors and structure-activity relationships.

Authors:  Jiawang Liu; Jayalakshmi Sridhar; Maryam Foroozesh
Journal:  Molecules       Date:  2013-11-25       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.